Are purines mediators of the anticonvulsant/neuroprotective effects of ketogenic diets?

Trends in Neurosciences

Volumn 31, Issue 6, 2008, Pages 273-278

  Masino, Susan A ^a   Geiger, Jonathan D ^b  

^a TRINITY COLLEGE   (United States)

^b UNIVERSITY OF NORTH DAKOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; PURINE;

ANTICONVULSANT ACTIVITY; ARTICLE; ASTROCYTE; BIOENERGY; BIOGENESIS; BRAIN REGION; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; DIET RESTRICTION; ENERGY METABOLISM; FOREBRAIN; HUMAN; KETOGENESIS; KETOGENIC DIET; LOW CARBOHYDRATE DIET; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; SEIZURE; SIGNAL TRANSDUCTION; SLEEP INDUCTION;

ANIMALS; BRAIN DISEASES; DIET, CARBOHYDRATE-RESTRICTED; HUMANS; NEUROPROTECTIVE AGENTS; PURINES;

EID: 44549083390     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tins.2008.02.009     Document Type: Article

References (70)

1. Wilder R.M. The effects of ketonemia on the course of epilepsy. Mayo Clin. Proc. 2 (1921) 307-308
2. Hallbook T., et al. Effects of ketogenic diet on epileptiform activity in children with therapy resistant epilepsy. Epilepsy Res. 77 (2007) 134-140
3. Freeman J.M., et al. The ketogenic diet: one decade later. Pediatrics 119 (2007) 535-543
4. Gasior M., et al. Neuroprotective and disease-modifying effects of the ketogenic diet. Behav. Pharmacol. 17 (2006) 431-439
5. Bough K.J., and Rho J.M. Anticonvulsant mechanisms of the ketogenic diet. Epilepsia 48 (2007) 43-58
6. Kim J.Y., and Lee H.W. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy. Epilepsia 48 (2007) 1366-1370
7. Greene A.E., et al. Perspectives on the metabolic management of epilepsy through dietary reduction of glucose and elevation of ketone bodies. J. Neurochem. 86 (2003) 529-537
8. Hartman A.L., and Vining E.P. Clinical aspects of the ketogenic diet. Epilepsia 48 (2007) 31-42
9. Meldrum B.S., and Rogawski M.A. Molecular targets for antiepileptic drug development. Neurotherapeutics 4 (2007) 18-61
10. Schwartzkroin P.A. Mechanisms underlying the anti-epileptic efficacy of the ketogenic diet. Epilepsy Res. 37 (1999) 171-180
11. Nakazawa M., et al. Effects of ketogenic diet on electroconvulsive threshold and brain contents of adenosine nucleotides. Brain Dev. 5 (1983) 375-380
12. DeVivo D.C., et al. Chronic ketosis and cerebral metabolism. Ann. Neurol. 3 (1978) 331-337
13. Bough K.J., et al. Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet. Ann. Neurol. 60 (2006) 223-235
14. Garriga-Canut M., et al. 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 9 (2006) 1382-1387
15. Kato F., et al. ATP- and adenosine-mediated signaling in the central nervous system: synaptic purinoceptors: the stage for ATP to play its "dual-role". J. Pharmacol. Sci. 94 (2004) 107-111
16. Klotz K.N. Adenosine receptors and their ligands. N-S Arch. Pharmacol. 362 (2000) 382-391
17. Boison D. Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Trends Pharmacol. Sci. 27 (2006) 652-658
18. Gouder N., et al. Seizure suppression by adenosine A1 receptor activation in a mouse model of pharmacoresistant epilepsy. Epilepsia 44 (2003) 877-885
19. Fedele D.E., et al. Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp. Neurol. 200 (2006) 184-190
20. Gouder N., et al. Overexpression of adenosine kinase in epileptic hippocampus contributes to epileptogenesis. J. Neurosci. 24 (2004) 692-701
21. Thummler S., and Dunwiddie T.V. Adenosine receptor antagonists induce persistent bursting in the rat hippocampal CA3 region via an NMDA receptor-dependent mechanism. J. Neurophysiol. 83 (2000) 1787-1795
22. Boison D. Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. Neurodegener. Dis. 4 (2007) 28-33
23. Volonte C., et al. P2 receptor web: complexity and fine-tuning. Pharmacol. Ther. 112 (2006) 264-280
24. Khakh B.S., et al. ATP modulation of excitatory synapses onto interneurons. J. Neurosci. 23 (2003) 7426-7437
25. Franke H., and Illes P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol. Ther. 109 (2006) 297-324
26. Sun, X.L. et al. (2007) K(ATP) channel openers facilitate glutamate uptake by GluTs in rat primary cultured astrocytes. Neuropsychopharmacology 10.1038/sj.npp.1301501
27. Nistico R., et al. The blockade of K(+)-ATP channels has neuroprotective effects in an in vitro model of brain ischemia. Int. Rev. Neurobiol. 82 (2007) 383-395
28. Dunwiddie T.V., et al. Adenine nucleotides undergo rapid, quantitative conversion to adenosine in the extracellular space in rat hippocampus. J. Neurosci. 17 (1997) 7673-7682
29. Fellin T., et al. Astrocytes coordinate synaptic networks: balanced excitation and inhibition. Physiology (Bethesda) 21 (2006) 208-215
30. Dunwiddie T.V., and Diao L.H. Extracellular adenosine concentrations in hippocampal brain slices and the tonic inhibitory modulation of evoked excitatory responses. J. Pharmacol. Exp. Ther. 268 (1994) 537-545
31. Lloyd H.G.E., et al. Intracellular formation and release of adenosine from rat hippocampal slices evoked by electrical stimulation or energy depletion. Neurochem. Int. 23 (1993) 173-185
32. Frenguelli B.G., et al. Temporal and mechanistic dissociation of ATP and adenosine release during ischaemia in the mammalian hippocampus. J. Neurochem. 101 (2007) 1400-1413
33. Dunwiddie T.V., and Masino S.A. The role and regulation of adenosine in the central nervous system. Annu. Rev. Neurosci. 24 (2001) 31-55
34. Dulla C.G., et al. Adenosine and ATP link PCO2 to cortical excitability via pH. Neuron 48 (2005) 1011-1023
35. Xiong Z.Q., et al. Activity-dependent intracellular acidification correlates with the duration of seizure activity. J. Neurosci. 20 (2000) 1290-1296
36. Halassa M.M., et al. The tripartite synapse: roles for gliotransmission in health and disease. Trends Mol. Med. 13 (2007) 54-63
37. Tian G.F., et al. An astrocytic basis of epilepsy. Nat. Med. 11 (2005) 973-981
38. Bains J.S., and Oliet S.H. Glia: they make your memories stick!. Trends Neurosci. 30 (2007) 417-424
39. Pascual O., et al. Astrocytic purinergic signaling coordinates synaptic networks. Science 310 (2005) 113-116
40. Oberheim N.A., et al. Astrocytic complexity distinguishes the human brain. Trends Neurosci. 29 (2006) 547-553
41. Li T., et al. Adenosine kinase is a target for the prediction and prevention of epileptogenesis. J. Clin. Invest. 118 (2008) 571-582
42. Peters A., et al. The selfish brain: competition for energy resources. Neurosci. Biobehav. Rev. 28 (2004) 143-180
43. Oltmanns K.M., et al. Differential energetic response of brain vs. skeletal muscle upon glycemic variations in healthy humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008) R12-R16
44. 31P spectroscopic imaging at 4.1 T. Epilepsia 40 (1999) 703-707
45. Thio L.L., et al. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 54 (2000) 325-331
46. Musa-Veloso K., et al. Breath acetone predicts plasma ketone bodies in children with epilepsy on a ketogenic diet. Nutrition 22 (2006) 1-8
47. 1H-MRS in patients with epilepsy controlled by ketogenic diet. MAGMA 8 (1999) 33-42
48. Gasior M., et al. The anticonvulsant activity of acetone, the major ketone body in the ketogenic diet, is not dependent on its metabolites acetol, 1,2-propanediol, methylglyoxal, or pyruvic acid. Epilepsia 48 (2007) 793-800
49. Bough K.J., et al. Evidence against enhanced glutamate transport in the anticonvulsant mechanism of the ketogenic diet. Epilepsy Res. 74 (2007) 232-236
50. Hood V.L. pH regulation of endogenous acid production in subjects with chronic ketoacidosis. Am. J. Physiol. 249 (1985) F220-F226
51. al-Mudallal A.S., et al. Diet-induced ketosis does not cause cerebral acidosis. Epilepsia 37 (1996) 258-261
52. Guzman M., and Blazquez C. Is there an astrocyte-neuron ketone body shuttle?. Trends Endocrinol. Metab. 12 (2001) 169-173
53. Ma W., et al. Ketogenic diet metabolites reduce firing in central neurons by opening K(ATP) channels. J. Neurosci. 27 (2007) 3618-3625
54. Andoh T., et al. A1 adenosine receptor-mediated modulation of neuronal ATP-sensitive K channels in rat substantia nigra. Brain Res. 1124 (2006) 55-61
55. Zhao Y.T., et al. 2-Deoxy-D-glucose-induced changes in membrane potential, input resistance, and excitatory postsynaptic potentials of CA1 hippocampal neurons. Can. J. Physiol. Pharmacol. 75 (1997) 368-374
56. Minor T.R., et al. Escape deficits induced by inescapable shock and metabolic stress are reversed by adenosine receptor antagonists. Behav. Brain Res. 120 (2001) 203-212
57. Basheer R., et al. Adenosine and sleep-wake regulation. Prog. Neurobiol. 73 (2004) 379-396
58. Fredholm B.B. Adenosine and neuroprotection. Int. Rev. Neurobiol. 40 (1997) 259-280
59. Hallbook T., et al. Ketogenic diet improves sleep quality in children with therapy-resistant epilepsy. Epilepsia 48 (2007) 59-65
60. Prins M.L., et al. Age-dependent reduction of cortical contusion volume by ketones after traumatic brain injury. J. Neurosci. Res. 82 (2005) 413-420
61. Yamada K.A., et al. Ketogenic diet reduces hypoglycemia-induced neuronal death in young rats. Neurosci. Lett. 385 (2005) 210-214
62. Stafstrom C.E. Dietary approaches to epilepsy treatment: old and new options on the menu. Epilepsy Curr. 4 (2004) 215-222
63. Dragunow M. Adenosine: the brain's natural anticonvulsant?. Trends Pharmacol. Sci. 7 (1986) 128-130
64. Otsuguro K., et al. Involvement of adenosine in depression of synaptic transmission during hypercapnia in isolated spinal cord of neonatal rats. J. Physiol. 574 (2006) 835-847
65. Gourine A.V., et al. ATP is a mediator of chemosensory transduction in the central nervous system. Nature 436 (2005) 108-111
66. Newby A.C. Adenosine and the concept of "retaliatory metabolites". Trends Biochem. Sci. 9 (1984) 42-44
67. Masino S.A., et al. Modulation of hippocampal glutamatergic transmission by ATP is dependent on adenosine a(1) receptors. J. Pharmacol. Exp. Ther. 303 (2002) 356-363
68. Hartman A.L., et al. The neuropharmacology of the ketogenic diet. Pediatr. Neurol. 36 (2007) 281-292
69. Jacobson K.A., and Gao Z.G. Adenosine receptors as therapeutic targets. Nat. Rev. Drug Discov. 5 (2006) 247-264
70. Holloway R., et al. Effect of lactate therapy upon cognitive deficits after traumatic brain injury in the rat. Acta Neurochir. (Wien) 149 (2007) 919-927